Page 12 - Randlab Global Product Brochure
P. 12

12 RespiratoryProducts
Airway tmpsTM
APVMA Approval No. 61474/500/0807 (Australia) | ACVM No. A10158 (New Zealand)
Oral bronchodilator and antibacterial for the
treatment of respiratory diseases in horses
Oral Administration In Horses
ACTIVE CONSTITUENTS
Clenbuterol Hydrochloride 21.44 ug/g Sulfadiazine 335 mg/g
Trimethoprim 67 mg/g
PACK SIZE 500g tub
Pharmacology
One level scoop (9g) orally per 250kg bodyweight to be added to feed twice daily for 6 to 10 days. Twice daily dosing is recommended to maintain therapeutic levels of active drugs in all situations.
Tips
Clenbuterol is a bronchodilator with minimal effect on the cardiovascular system. Clenbuterol also has a stabilising effect on mast cells, preventing the release of histamine, serotonin and bradykinin, therefore has a beneficial effect to clear mucociliary discharge. The spectrum of bacteria sensitive to this antibiotic combination includes; Staphylococci, Streptococci, Fusobacterium, Eneterobacter, Corynebacterium (excluding Rhodococcus equi), Salmonella, Shigella, Klebsiella, Pasteurella, Haemophilus, Proteus spp and most E.coli, some Brucella and Nocardia spp. Most Pseudomonas spp are insensitive. Bacterial culture and sensitivity testing should be carried out in cases of non-responsive or chronic infection.
Handling Precautions
May be harmful if swallowed. May cause skin irritation. Repeated exposure may cause skin allergy. May cause eye irritation. Avoid inhalation. May cause respiratory sensitisation. Trimethoprim possibly may affect bone.
Meat Withholding Period: Nil.
Racing/Event Withholding Period: If used in performance animals, the regulations of the relevant authorities regarding medication should be observed.
First Aid: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126 or in New Zealand 0800 764 766.
Disposal: Dispose of empty container by wrapping with paper and putting in garbage. Discarded needles/ sharps should immediately be placed in a designated and appropriately labelled “sharps” container.
Storage: Store below 30°C (Room temperature). Protect from light.
Airway Tmps Oral Powder is formulated for the treatment of respiratory disease in horses caused by organisms susceptible to trimethoprim and sulfadiazine combination therapy. It is for treatment of respiratory conditions characterised by restriction or obstruction of airways, including bronchospasm and obstruction resulting from bacterial and viral infection, bronchitis and bronchopneumonia. Airway Tmps Oral Powder is indicated whenever bronchodilation and antibacterial protection is desirable. Clenbuterol is a sympathomimetic amine that blocks beta2-receptor sites in the body, including those in lungs and uterus. This allows for maximum bronchodilation with improved pulmonary ventilation and mucus clearance without significant effects on the heart and blood vessels.
Indications
For the treatment of respiratory disease in horses caused by organisms susceptible to a trimethoprim/sulfadiazine combination. Treatment of respiratory conditions characterised by restriction of the airways, including bronchospasm and obstruction resulting from bacterial and viral infection, bronchitis and bronchopneumonia. Indicated where bronchodilation and antibacterial protection is desirable.
Contraindications
Airway Tmps Oral Powder will potentiate the action of corticosteroids, and antagonise the effects of prostaglandin F2alpha and oxytocin. Beta adrenergic agents adversely affect the action of Airway Tmps. Concurrent treatment of horses with these medications is not recommended. Airway Tmps Oral Powder should not be used in horses during the last 14 days of gestation, as uterine contractions may be prevented.
www.randlab.com.au
12


































































































   10   11   12   13   14